Coxiella burnetii (Q Fever)

Q fever is a zoonotic infection — a disease that spreads from animals to people — caused by a tiny, remarkably tough bacterium called Coxiella burnetii. The odd one-letter name has an honest origin: when the illness was first described among Australian slaughterhouse workers in the 1930s, nobody knew what caused it, so it was labeled “query fever” — the “Q” simply stood for query, a question mark. Most people who catch it get a flu-like illness that clears on its own, and many never feel sick at all. But Coxiella has two features that make it worth understanding: it is astonishingly infectious — inhaling just a few organisms can be enough — and in a small group of vulnerable people it can settle quietly into a damaged heart valve or blood vessel and cause a dangerous, long-simmering infection months or years later. This page explains what the bacterium is, how it reaches people (mostly on the wind, from livestock), the difference between the mild acute illness and the serious chronic form, and how doctors diagnose, treat, and prevent it.

Overview: What Q Fever Is
The Bacterium
How It Spreads
Acute Q Fever
Chronic Q Fever — The Serious One
Who Is Most at Risk
Diagnosis
Treatment
Prevention
The Honest Bottom Line
Research Papers
Connections
Featured Videos

Overview: What Q Fever Is

Q fever is an infection you usually catch from farm animals without ever touching them — most often by breathing in contaminated dust or fine airborne droplets. The bacterium lives quietly in cattle, sheep, and especially goats, and pours out in enormous numbers when those animals give birth. Carried on the wind in dust, dried birth fluids, wool, or straw, it can drift to farm workers and even to ordinary people living nearby.

The name is a genuine historical curiosity. The Australian doctor Edward Derrick investigated a cluster of feverish abattoir workers in Brisbane in 1935 and, unable to identify the cause, called it “query fever.” The organism was eventually identified and named Coxiella burnetii after two scientists who studied it, Herald Cox and Frank Macfarlane Burnet. The “Q” stuck.

For most people, Q fever is a self-limiting flu-like illness — unpleasant but not dangerous. The reason it earns a dedicated page is the minority of cases that matter enormously: people with heart-valve problems, artery aneurysms or grafts, weakened immune systems, or a pregnancy can develop a chronic, life-threatening infection. Knowing who is at risk — and catching the problem early — is the whole game.

The Bacterium

Coxiella burnetii is a small, gram-negative bacterium that is an obligate intracellular organism — it can only multiply inside the cells of its host, particularly the immune cells called macrophages. Unusually, it thrives inside the cell's acidic digestive compartment (the phagolysosome), the very environment most bacteria are destroyed in. This intracellular hideout is one reason the infection can be so stubborn and why treatment sometimes has to be prolonged.

Its most striking feature is toughness. Coxiella can switch into a compact, spore-like form (sometimes called the small-cell variant) that is extraordinarily resistant to heat, drying, sunlight, and disinfectants. In this state it can survive in soil, dust, wool, and animal bedding for months to years. That environmental durability is exactly why the organism spreads so easily — it does not need a living host to persist between infections, and contaminated dust can stay dangerous long after the animals are gone.

Combine that hardiness with a very low infectious dose and you get a genuinely formidable germ. Studies consistently report that inhaling just a handful of organisms — in some estimates as few as one to ten — can cause disease. Because of this, and because it survives so well as an aerosol, Coxiella burnetii is classified as a potential bioterrorism agent (a U.S. CDC Category B agent) and is handled as a regulated “select agent” in laboratories. This is not a reason for public alarm — natural, everyday Q fever comes from farms, not from any deliberate act — but it explains why the bacterium is treated with such caution in the lab.

How It Spreads

The dominant route by far is inhaling contaminated aerosols and dust. You do not need direct contact with an animal. The key sources are:

Birth products of infected livestock. When an infected cow, sheep, or goat gives birth (or miscarries), the placenta and birthing fluids can contain staggering numbers of bacteria — up to around a billion organisms per gram of placenta. Goats and sheep are especially important, and the risk peaks during lambing and kidding season.
Windborne dust. Once dried, contaminated material becomes dust that can travel on the wind. This is why people who never set foot on a farm — but live downwind of one — can be infected. Contaminated wool, straw, hay, hides, and manure are all documented sources.
Unpasteurized (raw) milk and dairy. Drinking raw milk from infected animals can transmit the organism, though this route seems less likely to cause severe illness than inhalation.
Occupational exposure. Q fever is classically an occupational disease of farmers, ranchers, veterinarians, shearers, and abattoir (slaughterhouse) and meat-processing workers. Laboratory staff who handle the organism or infected animals are also at risk.
Ticks (rarely). Ticks help maintain the bacterium in wild and domestic animal populations, but direct tick-to-human transmission is considered rare and is not a major route for people.

Person-to-person spread is very uncommon. In practice, if you are infected, the trail almost always leads back to livestock, their birthing environment, or the dust and materials around them.

Acute Q Fever

After exposure, symptoms — when they appear — usually begin about two to three weeks later. A large share of infections, by many estimates up to around 60%, cause no symptoms at all and are only ever detected by blood tests.

When acute Q fever does make someone ill, it typically looks like a bad flu:

High fever, often with drenching sweats and shaking chills.
Severe headache — frequently described as behind the eyes — which is a characteristic feature.
Muscle aches (myalgia), profound fatigue, and a general sick, run-down feeling.

Most people recover on their own within a week or two. But acute Q fever has two organ-specific faces that can make it more serious:

Atypical pneumonia. A cough and lung inflammation, sometimes with abnormal chest X-rays, that can resemble other “walking pneumonias.” It is usually mild but occasionally severe.
Hepatitis. Inflammation of the liver, often showing up as abnormal liver blood tests, sometimes with a distinctive pattern on liver biopsy. Most cases resolve, but it can cause noticeable illness.

Death from acute Q fever is uncommon in otherwise healthy people. The bigger long-term concern is not the acute illness itself but whether the infection will later evolve into the chronic form in a vulnerable person.

Chronic Q Fever — The Serious One

Chronic Q fever is the reason this infection deserves real respect. It develops in only a small fraction of infected people — roughly a few percent — but it can be deadly, and it can surface months or even years after the original exposure, long after any acute illness has been forgotten. It happens when Coxiella establishes a persistent, smoldering infection in a spot the immune system cannot easily clear.

The classic and most dangerous form is endocarditis — infection of a heart valve. What makes Q fever endocarditis so treacherous is that it is “culture-negative”: the standard blood cultures used to diagnose valve infections come back sterile because the organism will not grow in ordinary culture. A patient can be quietly deteriorating — fatigue, weight loss, low-grade fevers, worsening heart failure — while routine tests keep coming back “normal.” Q fever is one of the leading identifiable causes of culture-negative endocarditis worldwide.

The people who develop chronic Q fever almost always have a predisposing condition:

Pre-existing heart-valve disease or a prosthetic (artificial) valve — the single biggest risk factor for Q fever endocarditis.
Aneurysms or vascular grafts — the bacterium can seed a bulging or artificial section of artery, causing a life-threatening infected aneurysm or graft infection.
A weakened immune system — from disease or immunosuppressive drugs.
Pregnancy (discussed below).

Pregnancy risks. Q fever during pregnancy is a special concern. Infection can lead to miscarriage, stillbirth, premature birth, or low birth weight, and pregnant women are at higher risk of the infection persisting. The placenta can become heavily infected. Because of these stakes, pregnant women with Q fever are managed differently from other patients (see Treatment).

Left untreated, chronic Q fever endocarditis is frequently fatal. Treated properly — but the treatment is long and demanding.

Who Is Most at Risk

Two separate questions matter here: who is most likely to catch Q fever, and who is most likely to be seriously harmed by it.

Most likely to be infected:

People with direct livestock or farm exposure — farmers, ranchers, veterinarians, shearers, abattoir and meat workers, and laboratory personnel.
People who live downwind of, or near, infected farms, even without any animal contact.
People who consume unpasteurized milk or dairy.

Most likely to be seriously harmed (i.e., to progress to chronic disease):

Anyone with heart-valve disease or a prosthetic valve.
Anyone with an aneurysm or a vascular graft.
People who are immunocompromised.
Pregnant women.

The starkest illustration of how far Q fever can reach is the Netherlands outbreak of 2007–2010 — the largest recorded Q fever epidemic in history. It was driven by intensive dairy-goat farms experiencing waves of goat abortions, which released huge quantities of bacteria into the environment. The organism spread through the air to surrounding communities, and more than 4,000 people were diagnosed over several years (with many more likely infected without diagnosis). Living within a few kilometers of an affected farm was a clear risk factor. Ending the outbreak ultimately required drastic measures — vaccinating livestock and culling large numbers of pregnant goats. It is an honest, sobering reminder that Q fever is a genuine public-health problem, not merely an occupational curiosity, and that it can affect people who did nothing more than live in the wrong place.

Diagnosis

Q fever is easy to miss because its acute symptoms are so generic. Doctors usually need to actively think of it — often prompted by a history of farm, goat, or sheep exposure, or by an unexplained pneumonia, hepatitis, or culture-negative endocarditis.

Serology (antibody testing) is the mainstay. The most useful test measures antibodies against two forms of the bacterium, called phase I and phase II. The pattern is what distinguishes acute from chronic disease: in acute Q fever, phase II antibodies rise first and highest; in chronic Q fever, persistently high phase I antibody levels are the hallmark. This phase I versus phase II pattern is one of the more elegant diagnostic tricks in infectious disease.
PCR (detecting the bacterium's DNA) is valuable early in the illness, in the first week or two before antibodies have had time to develop, and can be run on blood or tissue.
Culture is hazardous and rarely done. Growing Coxiella requires a high-containment (BSL-3) laboratory because it is so infectious and is a regulated select agent. For this reason, if a clinician suspects Q fever, it is important to warn the laboratory in advance so staff can protect themselves — you never want a lab to unknowingly handle this organism on an open bench.
Imaging such as echocardiography (for the heart valves) and PET or CT scanning is used to hunt for the focus of chronic infection — an infected valve, aneurysm, or graft — once serology raises the alarm.

Treatment

Treatment depends entirely on which form of the disease is present.

Acute Q fever. The clear first-line antibiotic is doxycycline, typically for about two weeks. Prompt treatment shortens the illness and, importantly, may reduce the chance of progression to chronic disease. Many mild cases resolve on their own, but treatment is recommended for symptomatic patients.

Chronic Q fever (endocarditis and vascular infection). This is where treatment becomes a long-haul commitment. The standard regimen is doxycycline combined with hydroxychloroquine, continued for at least 18 months — and often longer (around 24 months) for infected prosthetic valves or grafts. Hydroxychloroquine is not just an add-on: it makes the acidic compartment where Coxiella hides less acidic, which allows doxycycline to actually kill the organism rather than merely hold it in check. This regimen requires careful monitoring — tracking phase I antibody levels to gauge response, and watching for hydroxychloroquine's main long-term risk, damage to the retina, with regular eye exams. Some patients also need surgery to replace an infected valve or repair an infected vessel.

Pregnancy. Doxycycline and hydroxychloroquine are generally avoided in pregnancy, so infected pregnant women are usually managed with long-term co-trimoxazole (trimethoprim–sulfamethoxazole) to suppress the infection and protect the pregnancy, with specialist care.

The key practical message: acute Q fever is a short, straightforward course of doxycycline, but chronic Q fever demands patience, combination therapy, months of treatment, and close monitoring.

Prevention

Because Coxiella is so widespread in livestock and so durable in the environment, prevention works on several fronts:

Control in animals. Vaccinating goats and sheep (a phase I animal vaccine is used in parts of Europe), managing herds during birthing season, and carefully disposing of placentas, birth fluids, and contaminated bedding all reduce how much bacteria enters the environment. Herd control was central to ending the Dutch outbreak.
Pasteurize milk. Pasteurization reliably kills Coxiella. Avoiding raw milk and raw-milk products removes that transmission route.
Protect at-risk workers. Good hygiene, protective clothing, and appropriate respiratory protection for farmers, vets, shearers, and abattoir and lab workers — especially around birthing animals — lowers occupational risk. In Australia, a licensed human vaccine (Q-VAX) is offered to high-risk workers, but it must be given only after pre-vaccination skin and antibody testing, because vaccinating someone already exposed can cause severe local reactions. No such vaccine is licensed in the United States.
Screen the vulnerable. This is arguably the most important individual-level protection. People with known heart-valve disease, prosthetic valves, aneurysms, or vascular grafts who may have been exposed should be screened with serology so that a brewing chronic infection can be caught and treated before it destroys a valve. Some experts recommend echocardiography for anyone diagnosed with acute Q fever to look for undiagnosed valve disease.

The Honest Bottom Line

Q fever is, for most people who catch it, a passing flu-like illness — and for many, no illness at all. It is not a reason for the average person to worry. But Coxiella burnetii earns genuine respect for three reasons: it is one of the most infectious bacteria known, needing only a handful of inhaled organisms; it survives in the environment for years, so it spreads on the wind from farms to whole communities; and in people with a damaged or artificial heart valve, an aneurysm, a weakened immune system, or a pregnancy, it can cause a hidden, culture-negative, potentially fatal chronic infection that surfaces long after exposure.

The practical takeaways are simple. If you work with or live near livestock — especially goats and sheep during birthing season — know that Q fever exists and mention that exposure to your doctor if you fall ill. Avoid raw milk. And if you have a heart-valve problem or a vascular graft and have any chance of exposure, ask about screening. Caught early, even the serious form is treatable; the danger lies in not thinking of it at all.

Research Papers

Maurin M, Raoult D. Q fever. Clinical Microbiology Reviews. 1999;12(4):518–553. doi:10.1128/CMR.12.4.518 — The landmark comprehensive review of Coxiella burnetii biology, transmission, acute and chronic disease, diagnosis, and treatment.
Parker NR, Barralet JH, Bell AM. Q fever. The Lancet. 2006;367(9511):679–688. doi:10.1016/S0140-6736(06)68266-4 — A concise clinical overview of Q fever for practitioners, covering presentation and management.
Eldin C, Mélenotte C, Mediannikov O, et al. From Q fever to Coxiella burnetii infection: a paradigm change. Clinical Microbiology Reviews. 2017;30(1):115–190. doi:10.1128/CMR.00045-16 — A major modern review reframing how persistent focalized Coxiella infections (endocarditis, vascular) are understood.
Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q fever. The Lancet Infectious Diseases. 2005;5(4):219–226. doi:10.1016/S1473-3099(05)70052-9 — Explains how host factors determine whether infection stays acute or becomes chronic.
Angelakis E, Raoult D. Q fever. Veterinary Microbiology. 2010;140(3–4):297–309. doi:10.1016/j.vetmic.2009.07.016 — Reviews the animal reservoirs (cattle, sheep, goats) and zoonotic transmission that drive human disease.
Marrie TJ. Coxiella burnetii pneumonia. European Respiratory Journal. 2003;21(4):713–719. doi:10.1183/09031936.03.00099703 — Focused review of the atypical-pneumonia presentation of acute Q fever.
Roest HIJ, Tilburg JJHC, van der Hoek W, et al. The Q fever epidemic in The Netherlands: history, onset, response and reflection. Epidemiology and Infection. 2011;139(1):1–12. doi:10.1017/S0950268810002268 — Documents the dairy-goat origin and course of the record 2007–2010 outbreak.
Schneeberger PM, Wintenberger C, van der Hoek W, Stahl JP. Q fever in the Netherlands – 2007–2010: what we learned from the largest outbreak ever. Médecine et Maladies Infectieuses. 2014;44(8):339–353. doi:10.1016/j.medmal.2014.02.006 — Lessons drawn from the Dutch epidemic on airborne spread and public-health response.
Million M, Thuny F, Richet H, Raoult D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. The Lancet Infectious Diseases. 2010;10(8):527–536. doi:10.1016/S1473-3099(10)70135-3 — A large long-term series of chronic Q fever endocarditis, informing the doxycycline–hydroxychloroquine regimen.
Fenollar F, Fournier PE, Carrieri MP, et al. Risks factors and prevention of Q fever endocarditis. Clinical Infectious Diseases. 2001;33(3):312–316. doi:10.1086/321889 — Identifies valvulopathy as a key risk and supports screening exposed patients with heart-valve disease.
Carcopino X, Raoult D, Bretelle F, et al. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clinical Infectious Diseases. 2007;45(5):548–555. doi:10.1086/520661 — Evidence that long-term co-trimoxazole reduces obstetric complications in pregnant women with Q fever.
Anderson A, Bijlmer H, Fournier PE, et al. Diagnosis and management of Q fever — United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recommendations and Reports. 2013;62(RR-03):1–30. PMID 23535757 — The U.S. CDC guideline on phase I/II serology, PCR, and doxycycline ± hydroxychloroquine treatment.

Back to Table of Contents

Connections